Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells $139,200.00 in Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 2,784 shares of Pro-Dex stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $50.00, for a total transaction of $139,200.00. Following the completion of the sale, the director now directly owns 295,810 shares in the company, valued at approximately $14,790,500. The trade was a 0.93 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Pro-Dex Trading Down 0.8 %

Shares of PDEX stock opened at $49.62 on Wednesday. The business’s fifty day moving average price is $39.93 and its 200 day moving average price is $39.61. The firm has a market capitalization of $161.81 million, a PE ratio of 24.69 and a beta of 0.68. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.58 and a quick ratio of 1.44. Pro-Dex, Inc. has a 1-year low of $16.84 and a 1-year high of $59.60.

Pro-Dex (NASDAQ:PDEX) last posted its quarterly earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. As a group, sell-side analysts forecast that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Pro-Dex from a “buy” rating to a “hold” rating in a research report on Wednesday, March 12th.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in PDEX. OMERS ADMINISTRATION Corp purchased a new stake in shares of Pro-Dex during the 4th quarter worth approximately $313,000. Millennium Management LLC acquired a new position in Pro-Dex during the fourth quarter worth $260,000. 683 Capital Management LLC purchased a new stake in Pro-Dex during the fourth quarter worth $739,000. Northern Trust Corp grew its holdings in Pro-Dex by 14.1% in the fourth quarter. Northern Trust Corp now owns 35,754 shares of the medical instruments supplier’s stock valued at $1,672,000 after purchasing an additional 4,426 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in shares of Pro-Dex in the fourth quarter valued at $433,000. 15.28% of the stock is owned by hedge funds and other institutional investors.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.